28 July 2023
28 July 2023
In the hunt for a functional cure for Hepatitis B, what treatment methods are researchers using? Are any trials close to finding one?
Eli Lilly continues to report positive data from multiple Phase III trials investigating tirzepatide while other GLP-1 agonists are in a negative media spotlight.
V116 showed a safety profile in line with the comparator in both trials.
At day 15, zuranolone offered an improvement of 50% or more in depressive symptoms in 57% of the subjects.
In the trial, TAK-994 was found to offer a statistically significant rise in daytime wakefulness.
No safety issues linked to the usage of Enhertu were reported in the trial.
RVT-3101 is also being investigated as a potential therapy for other inflammatory bowel diseases.
The company has partnered with Omico to enrol participants in the trials.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
